Terms: = Gastric cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Treatment
329 results:
1. Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for gastric cancer.
Ma Y; Jin J; Xue Z; Zhao J; Cai W; Zhang W
J Transl Med; 2024 Apr; 22(1):381. PubMed ID: 38654380
[TBL] [Abstract] [Full Text] [Related]
2. Nobiletin targets SREBP1/ACLY to induce autophagy-dependent cell death of gastric cancer cells through PI3K/Akt/mtor signaling pathway.
Chen M; Li H; Zheng S; Shen J; Chen Y; Li Y; Yuan M; Wu J; Sun Q
Phytomedicine; 2024 Jun; 128():155360. PubMed ID: 38547624
[TBL] [Abstract] [Full Text] [Related]
3. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mtor signaling axis by binding to MYH9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
4. Investigation on the mechanism of the combination of eremias multiocellata and cisplatin in reducing chemoresistance of gastric cancer based on
Cheng FE; Li Z; Bai X; Jing Y; Zhang J; Shi X; Li T; Li W
Aging (Albany NY); 2024 Feb; 16(4):3386-3403. PubMed ID: 38345573
[TBL] [Abstract] [Full Text] [Related]
5. Diterpenoid tanshinones inhibit gastric cancer angiogenesis through the PI3K/Akt/mtor signaling pathway.
Yu JR; Liu YY; Gao YY; Qian LH; Qiu JL; Wang PP; Zhang GJ
J Ethnopharmacol; 2024 Apr; 324():117791. PubMed ID: 38301987
[TBL] [Abstract] [Full Text] [Related]
6. HIPK3 maintains sensitivity to platinum drugs and prevents disease progression in gastric cancer.
Wu QN; Qi J; Liu ZK; Luo XJ; Yu K; Lu YX; Wang Y; Jin Y; Liu J; Huang LY; Zeng ZL; Zheng Y; Xu RH; Liu ZX
Cancer Lett; 2024 Mar; 584():216643. PubMed ID: 38246220
[TBL] [Abstract] [Full Text] [Related]
7. Chrysophanol induces apoptosis and ferroptosis of gastric cancer cells by targeted regulation of mtor.
Xi S; Ding W; Weng D; Zeng Y; Gao K; Wu Q; Huang G; Li Y; Yue H
Chem Biol Drug Des; 2024 Jan; 103(1):e14417. PubMed ID: 38230790
[TBL] [Abstract] [Full Text] [Related]
8. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of
Lung cancer].
Zhang Y; Wang Y; Liu M
Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978
[TBL] [Abstract] [Full Text] [Related]
9. [Preliminary Investigation of the Molecular Mechanism of Empagliflozin Suppressing gastric cancer Through Mammalian Target of Rapamycin].
Rao H; Cheng W; Yu J; An X; Deng H; Zhang Z; Wu F; Ji F; Li S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1146-1153. PubMed ID: 38162062
[TBL] [Abstract] [Full Text] [Related]
10. Dual PI3K/mtor inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU.
Zhong Z; Wang T; Zang R; Zang Y; Feng Y; Yan S; Geng C; Zhu N; Wang Q
Biomed Pharmacother; 2024 Jan; 170():116086. PubMed ID: 38159377
[TBL] [Abstract] [Full Text] [Related]
11. The role of α7-nAChR-mediated PI3K/AKT pathway in lung cancer induced by nicotine.
He Z; Xu Y; Rao Z; Zhang Z; Zhou J; Zhou T; Wang H
Sci Total Environ; 2024 Feb; 912():169604. PubMed ID: 38157907
[TBL] [Abstract] [Full Text] [Related]
12. Modified Chaishao Liujunzi Decoction inhibits bile acid-induced gastric intestinal metaplasia: from network prediction to experimental verification.
Sun Z; Liu Y; Deng H; Wang S; Zhang J; Xing C; Xu C
Aging (Albany NY); 2023 Dec; 15(23):13998-14018. PubMed ID: 38096029
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
14. Study the Anticancer Properties of Thymol-Loaded PEGylated Bovine Serum Albumin Nanoparticles Conjugated with Folic Acid.
Al-Salih MYA; Pouresmaeil V; Davoodi-Dehaghani F; Haghighi HN; Tabrizi MH
Chem Biodivers; 2023 Nov; 20(11):e202301122. PubMed ID: 37823866
[TBL] [Abstract] [Full Text] [Related]
15. Calcitriol suppresses gastric cancer progression and cisplatin resistance by inhibiting glycolysis and M2 macrophage polarization through inhibition of mtor activation.
Jie L; Hengyue W; Ting H
Environ Toxicol; 2024 Feb; 39(2):830-839. PubMed ID: 37792677
[TBL] [Abstract] [Full Text] [Related]
16. Synthesis and evaluation of biological effects of modified graphene oxide nanoparticles containing Lawson (Henna extract) on gastric cancer cells.
Alkwedhim MAH; Pouresmaeil V; Davoodi-Dehaghani F; Mahavar M; Homayouni Tabrizi M
Mol Biol Rep; 2023 Nov; 50(11):8971-8983. PubMed ID: 37715021
[TBL] [Abstract] [Full Text] [Related]
17. The potential effect and mechanism of Saikosaponin A against gastric cancer.
Wang C; Zhang R; Chen X; Yuan M; Wu J; Sun Q; Miao C; Jing Y
BMC Complement Med Ther; 2023 Aug; 23(1):295. PubMed ID: 37608281
[TBL] [Abstract] [Full Text] [Related]
18. Loss of RACK1 promotes glutamine addiction via activating AKT/mtor/ASCT2 axis to facilitate tumor growth in gastric cancer.
Chen M; Wang G; Xu Z; Sun J; Liu B; Chang L; Gu J; Ruan Y; Gao X; Song S
Cell Oncol (Dordr); 2024 Feb; 47(1):113-128. PubMed ID: 37578594
[TBL] [Abstract] [Full Text] [Related]
19. Tumor-associated macrophage-derived exosomal miR-513b-5p is a target of jianpi yangzheng decoction for inhibiting gastric cancer.
Zhang R; Chen X; Miao C; Chen Y; Li Y; Shen J; Yuan M; Chen M; Cheng J; Liu S; Sun Q; Wu J
J Ethnopharmacol; 2024 Jan; 318(Pt B):117013. PubMed ID: 37572927
[TBL] [Abstract] [Full Text] [Related]
20. Active ingredients Isorhamnetin of Croci Srigma inhibit stomach adenocarcinomas progression by MAPK/mtor signaling pathway.
Shi XF; Yu Q; Wang KB; Fu YD; Zhang S; Liao ZY; Li Y; Cai T
Sci Rep; 2023 Aug; 13(1):12607. PubMed ID: 37537191
[TBL] [Abstract] [Full Text] [Related]
[Next]
